Finding effective ways to reduce HIV risk among substance-using men who have sex with men.
Leveraging data synthesis to identify optimal and robust strategies for HIV elimination among substance-using MSM
This study looks at how drinking alcohol and using methamphetamine might increase the risk of HIV in men who have sex with men, and it aims to find the best ways to help keep them safe by understanding their behaviors around condom use and HIV medications.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11059905 on NIH RePORTER |
What this research studies
This research investigates how alcohol and methamphetamine use affects the risk of HIV among men who have sex with men (MSM). It aims to understand the specific behaviors that contribute to this risk, such as condom use and adherence to HIV medications. By synthesizing existing data and using advanced modeling techniques, the project seeks to identify the most effective strategies for reducing HIV transmission in this population. The findings could help tailor interventions to better meet the needs of MSM who use substances.
Who could benefit from this research
Good fit: Ideal candidates for this research are men who have sex with men and engage in alcohol or methamphetamine use.
Not a fit: Patients who do not use substances or who are not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention strategies that significantly reduce HIV transmission among substance-using MSM.
How similar studies have performed: Previous research has shown promise in understanding the relationship between substance use and HIV risk, indicating that this approach could yield valuable insights.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Janulis, Patrick Francis — Northwestern University at Chicago
- Study coordinator: Janulis, Patrick Francis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.